305 related articles for article (PubMed ID: 27383203)
1. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
2. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
4. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
Qureshi HY; Ricci G; Zafarullah M
Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus-miRNA-BART6-5p regulates TGF-β/SMAD4 pathway to induce glycolysis and enhance proliferation and metastasis of gastric cancer cells.
Zhao X; Huang X; Dang C; Wang X; Qi Y; Li H
Oncol Res; 2024; 32(5):999-1009. PubMed ID: 38686046
[TBL] [Abstract][Full Text] [Related]
6. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
[TBL] [Abstract][Full Text] [Related]
7. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
8. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
Song H; Guo B; Zhang J; Song C
Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
Soond SM; Chantry A
Oncogene; 2011 May; 30(21):2451-62. PubMed ID: 21258410
[TBL] [Abstract][Full Text] [Related]
13. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
[TBL] [Abstract][Full Text] [Related]
16. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
17. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
18. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.
Kong W; Yang H; He L; Zhao JJ; Coppola D; Dalton WS; Cheng JQ
Mol Cell Biol; 2008 Nov; 28(22):6773-84. PubMed ID: 18794355
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways.
Fu H; Hu Z; Wen J; Wang K; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):648-56. PubMed ID: 19657566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
